Phoenix Financial Ltd. Grows Stock Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Phoenix Financial Ltd. increased its stake in Intuitive Surgical, Inc. by 7.3%, owning 15,295 shares valued at approximately $8.29 million.
• Analysts have varied opinions on Intuitive Surgical, with an average price target of $580.29 and ratings ranging from Buy to Sell.
• Insider sales included a significant transaction by CEO Gary S. Guthart, selling 29,360 shares for about $13.87 million, representing a nearly 60% reduction in his ownership.

Phoenix Financial Ltd. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 7.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,295 shares of the medical equipment provider's stock after acquiring an additional 1,035 shares during the quarter. Phoenix Financial Ltd.'s holdings in Intuitive Surgical were worth $8,288,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Aaron Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 0.8% in the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider's stock valued at $1,374,000 after purchasing an additional 19 shares during the last quarter. Crown Wealth Group LLC increased its holdings in shares of Intuitive Surgical by 4.8% in the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock valued at $218,000 after purchasing an additional 20 shares during the last quarter. FSM Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 3.8% in the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock valued at $270,000 after purchasing an additional 20 shares during the last quarter. CFO4Life Group LLC increased its holdings in shares of Intuitive Surgical by 4.8% in the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock valued at $216,000 after purchasing an additional 20 shares during the last quarter. Finally, J. W. Coons Advisors LLC increased its holdings in shares of Intuitive Surgical by 1.4% in the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider's stock valued at $741,000 after purchasing an additional 20 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent research reports. Truist Financial cut their price target on Intuitive Surgical from $600.00 to $525.00 and set a "buy" rating for the company in a report on Wednesday, October 15th. Deutsche Bank Aktiengesellschaft reissued a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. UBS Group set a $529.00 target price on Intuitive Surgical in a research note on Monday, October 13th. Royal Bank Of Canada reissued an "outperform" rating and set a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Finally, Mizuho cut their target price on Intuitive Surgical from $570.00 to $520.00 and set a "neutral" rating for the company in a research note on Tuesday, October 14th. Fourteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $580.29.

Insider Transactions at Intuitive Surgical

In other news, insider Gary S. Guthart sold 29,360 shares of the firm's stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Amy L. Ladd sold 336 shares of the firm's stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the transaction, the director owned 1,074 shares of the company's stock, valued at approximately $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock worth $21,716,492 over the last ninety days. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 2.8%

ISRG opened at $458.47 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business has a fifty day simple moving average of $454.70 and a 200-day simple moving average of $495.81. The firm has a market cap of $164.35 billion, a P/E ratio of 63.94, a P/E/G ratio of 4.69 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the business posted $1.78 earnings per share. The company's quarterly revenue was up 21.4% on a year-over-year basis. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.